newsfilter
← Latest News
Business Wire·

Kiromic BioPharma Arranges Up to $10 Million Financing

Litigation with Sabby and Another Institutional Shareholder Settled Kiromic BioPharma, Inc. (NASDAQ:KRBP) ("Kiromic" or the "Company"), a clinical-stage fully-integrated biotherapeutics company using its proprietary